Public Health England exists to protect and improve the nation's health and wellbeing, and reduce health inequalities. We do this through world-leading science, research, knowledge and intelligence, advocacy, partnerships and the delivery of specialist public health services. We are an executive agency of the Department of Health and Social Care, and a distinct delivery organisation with operational autonomy. We provide government, local government, the NHS, Parliament, industry and the public with evidence-based professional, scientific and delivery expertise and support.
Introduction
There is wide recognition both internationally and nationally in England that the population health challenges facing future generations require health systems to reconfigure the way primary and secondary care services are delivered to patients 1 . Service reconfiguration is always complex and often high profile and political, particularly where it is perceived that a certain population group may be disadvantaged by such change 2, 3 . In England, the National Health Service (NHS) has a lengthy assurance process aimed at ensuring service reconfiguration is safe and effective 4 . Part of this process involves obtaining independent clinical advice on proposals for service change and this role is fulfilled through 12 Clinical Senates established in 2013, which comprise a range of clinical specialists 5 .
A preliminary review of completed Clinical Senate assessments found that more than half of service change proposals contained some elements of what we have termed for the purpose of this research a 'multiple site, single service' (MSSS) model. These models describe a method of delivering care across more than one clinical site or location, often across a regional geography, via a single clinical service or team. Frequently, these models are proposed to avoid full 'consolidation' or 'centralisation' of services which, as previously highlighted, can be particularly high profile, politically contentious and can result in access inequalities for hard to reach parts of the population.
However, there is no summary of the evidence base for these models of care or guidance available to inform the decision regarding their adoption and implementation. This is a significant evidence gap facing commissioners and providers redesigning clinical services. Recent reviews in the East Midlands 6 , London 7, 8 and Yorkshire and the Humber 9 highlighted the challenge of evaluating these models which are often at odds with national service specifications and/or clinical evidence.
This scoping review therefore aims to address the following three research questions: Two authors (PL and MD) designed the search strategy to enhance sensitivity. Three medical databases were selected to search: CINAHL, MEDLINE and EMBASE. Two management databases (HMIC and HBE) and one for social science research (Social P&P) were also searched.
An initial scoping search was conducted to look for possible keywords and free text terms, which were then matched to their Medical Subject Headings (MeSH) on Medline. These were then discussed by the CWG and the final list of terms agreed.
The search strategy devised was based on 4 key concepts. The first related to the model of care; terms used included 'clinical network', 'cross-site working', and 'integrated service', among others. The second set of key terms isolated papers involving secondary care services which was agreed as the focus of this review by the Clinical Working Group. The third ensured the results were limited to studies published from OECD countries to ensure the healthcare systems were drawn from an internationally recognised grouping of developed countries where comparisons with the United Kingdom's NHS could be made. The final set of terms related to possible reported outcomes, including 'access', 'patient experience' and 'quality'. The full search strategy is included in Appendix B.
Study selection was completed by 2 authors (DB and MD), with disagreements about inclusion being resolved by consensus, with referral to a third reviewer (BP) if this could not be achieved.
All study types were considered for inclusion if they were published in a peer-reviewed journal and related to health services based in OECD countries. Given the nature of the review topic, studies were only included if their focus was the delivery of a single clinical service working across multiple hospital or provider sites or geographic locations or whose focus was an established model of service delivery.
Studies were excluded if they were published before 2013, prior to the main policy drivers for MSSS models being introduced in the UK. Studies were also excluded if they were not published in English.
Quality assessment
Quality assessment of included studies were completed by 8 authors (DB, MD, EI, RP, BP, RW, SM, CG) and collated by 2 authors (DB and MD).
The Public Health Ontario Meta-tool for Quality Appraisal of Public Health Evidence (MetaQAT) was used as a quality assessment tool 10 . This was chosen due to its successful validation for use in mixed-methods systematic reviews.
No study was excluded on the basis of the quality assessment, although the limitations of available evidence and potential for bias were taken account of in synthesis and interpretation of findings.
Data extraction and synthesis
Data was extracted by 2 authors (DB and MD) using a standardised data extraction form.
An integrated methodology was used to collate study findings and allow the results of quantitative and qualitative studies to be synthesised 11 . This approach was chosen due to the significant heterogeneity in the identified studies, particularly in relation to methodology and reported outcomes. For this reason, statistical analysis (including meta-analysis) was not feasible or appropriate.
A thematic analysis was conducted to identify common elements between studies. The findings and reported outcomes of all included studies were then organised using identified themes as subject headings to allow a narrative synthesis to be completed. Emerging themes were discussed between the lead authors and the wider Clinical Working Group.
The below PRISMA diagram outlines the screening process.
Figure 1. PRISMA Diagram of Screening Process

Results
Study inclusion and study characteristics
After screening by title and abstract, the full texts of 47 studies were reviewed to determine eligibility. After applying the inclusion and exclusion criteria, 18 studies were included in the review. A full list of included studies is in Appendix C.
The search and screening process produced a mix of empirical studies (n=16) and descriptive or expert opinion articles (n=2). As per the agreed inclusion criteria, all were included for analysis. Most studies (n=11) reported on service reorganisation undertaken in the UK. The other research identified originated in Australia (n=3), Canada (n=1), the United States (n=1), New Zealand (n=1) and Sweden (n=1). No study reported on a service change or delivery taking place prior to 2000, with the majority reporting service change from 2010 onwards (n=10).
The studies referenced a range of different clinical services, with Stroke Medicine (n=4) being the most commonly reported, followed by Surgery (n=4), Cardiology (n=2) and Oncology (n=2). In 4 studies, models of care were discussed without reference to an individual specialty, either because the service delivery cut across numerous different specialties or findings were presented without reference to a particular clinical service (eg qualitative research exploring views of hospital administrators).
There is significant variation in the methodology of the included empirical studies. Many different study types are represented, with the most frequently reported being cohort (n=4) and mixed methods (n=4).
The study period also varied significantly; a retrospective data analysis of 9 years of clinical records was the longest included. Most quantitative studies reported more than 12 months of outcome data following a service change, whilst data from the qualitative studies were collected over a shorter time period.
Description of service reorganisation
This review was prompted by the lack of common definition for MSSS models of care. The included studies that described a service design in detail allowed common factors to be explored and thematic analysis to be undertaken. Table 1 describes the results of this analysis and outlines the distinct models identified and the variation between them, ordered by a progressive increase in the level of centralisation. 
Mortality
The most frequently reported patient measure was 30-day mortality. No study reported increased patient mortality after service reorganisation. Most studies found no statistically significant difference in mortality rates either between specialist centre and feeder hospital, or pre-and post-service reorganisation (see Agarwal et al 14 . This led many authors to conclude that the MSSS model of care introduced was safe. Tideman et al 17 , whose study examined the effect of a clinical cardiac support network on patient mortality showed a 22% relative risk reduction in mortality between patients treated in a rural network hospital vs. a rural non-network hospital. Additionally, the authors found a statistically significant improved mortality in specialist centres ('hubs') compared to rural network hospitals (Odds Ratio (OR) 1.46, CI 1.33-1.60).
Other patient outcomes
Other service-specific outcome measures were also occasionally reported. Moynihan et al 23 found centralising acute stroke care to a small number of regional specialist centres improved thrombolysis rates by more than 10% (a measure of statistical significance was not provided).
Some studies measured the occurrence of adverse events. Quinn et al 19 reported no increase of recurrence or atrophy when orchidopexy or inguinal herniotomy were performed by upskilled, networked general surgeons compared to specialist centre paediatric surgeons.
Likewise, Stub et al 15 found no increased rate of complications or adverse events amongst patients having trans-catheter aortic valve replacement (TAVI) in a network hospital compared to the previous specialist centre.
Tai et al 16 found that patients triaged and assessed at a 'feeder' hospital were more likely to be listed for transplant at the specialist centre despite no evidence of a difference in case mix (139/180 vs 312/475, P 0.005). The study also found that the MSSS model of care increased overall transplant activity. The authors found this was confirmatory evidence of the model's ability to increase access to a specialised service.
Proctor et al 18 found no difference in mortality between patients undergoing regional transfer for ruptured abdominal aortic aneurysm, but did find increased postoperative morbidity among patients who were transferred, which the authors ascribed to differences in preoperative management between 'feeder' hospitals and the specialist centre (complications seen in 35.9% of specialist centre patients vs 78.6% of feeder unit 1 patients and 70% of feeder unit 2 patients, P=0.006 and P=0.02 respectively). 
Reported impact on patient experience
Four studies reported data related to patient satisfaction with MSSS models of care, the results of which are included in Table 3 . The majority used surveys or questionnaires to capture this information (Grigg et al 24 Grigg et al 24 used postal and online surveys (6 weeks and 6 months after birth) to explore women's experiences of transfer from a 'feeder' hospital to a specialist centre for maternity care. The authors concluded that the most important factors to patients were a sense of control, communication, and relational continuity of care (ie cared for by a familiar midwife or clinician). The majority of women were not negatively impacted by the transfer, and those that were, were unhappy about the change to a prior agreed birth plan, rather than the transfer itself.
In a similar way, Moynihan et al 23 reported the findings of patient and carer questionnaire designed to capture the experience of being transferred to a Specialist Stroke Centre, particularly asking about the route of admission, communication, ease of visiting and repatriation. 90% of patients were happy with the transfer and only 11% felt it negatively affected the outcome of their care.
Svederud et al 25 conducted 20 interviews with patient representatives and collated 561 survey responses to identify patient attitudes to specialist centre provision and the impact of transfer from local 'feeder' hospitals. The most important aspects of care were reported to be the quality of care provided (98%), continuity of treatment (90%), and a well-functioning care pathway (83%). Also important to patients were an individualised care plan (79%), accessibility of information (72%), involvement in the care process (66%) and waiting time (66%). Interestingly, the least important aspect of the care was reported to be the geographical location of its delivery (49%).
Whilst Tai et al 16 found patient satisfaction with a MSSS care model to be high, there was a difference in opinion between patients cared for in a smaller network hospital, compared to patients cared for at the specialist centre. The overwhelming majority of patients treated in the network hospitals felt the service they received was safe (98%) and the ability to be cared for by a familiar clinician was also highly valued (87%). Whilst patients treated in the specialist centre also reported very high satisfaction levels with their care, they had a lack of confidence in the quality of care delivered in their local network hospital. This perhaps suggests patients do perceive care to be of better quality in specialist centres prior to their direct experience of a local networked site. Of those patients discharged directly home, the vast majority (90%) were happy to be transferred to a more remote specialist centre, and their experience of care was excellent.
Only a minority reported difficulties with access for visitors
Patient's views were also positive in those discharged back to a local stroke unit, although levels of satisfaction were not as high as in those discharged directly home, probably influenced by the increased stroke severity in this group About half were happy to be admitted to the remote specialist centre, whereas a third did not mind 13 ). The themes identified in those studies are included in Table 4 .
Imison et al 28 conducted a qualitative analysis of reports produced by the UK National Clinical Advisory Team (NCAT, forerunner to regional Clinical Senates) when assessing proposed service reorganisations. The 2 most significant drivers were found to be finance and workforce. Improving outcomes and patient safety were reported to be largely only secondary considerations. The exception to these findings was specialised services (commissioned by NHS England), where the main drivers for change were reported as Quality of Care and National Policy. Fulop et al 26 conducted 125 semi-structured interviews with staff from management and service delivery and reviewed 653 documents relating to the adoption of 2 MSSS models of care. The authors found that a single launch of the service redesign (a 'Big Bang launch') was preferable to a phased implementation period to focus the energies of staff and provide clarity of design and purpose. They also found simple, more inclusive referral pathways were required for change to be effective and that setting the reorganisation in the context of targeted improvement in standards increased the capacity and motivation of staff to deliver change.
Kash et al 13 also emphasise the importance of driving change with a clear communication of the culture and values of the organisation. This was important in ensuring any difference in values between staff and their departments was aligned, and staff had confidence to deliver change despite the associated risk. Strong leadership and good communication were also identified as important factors, as was the patient and staff engagement (particularly in reducing staff turnover and improving retention). Whilst this study provides a US-centric perspective on systems change, many of the factors identified are similar to those reported in UK-based studies.
O'Sullivan et al 20 report important factors relating to the success of MSSS models of care in rural Australia. Their conclusions are necessarily specific to the context of the Australian health system and geography, and highlight the differences in care provision between rural clinicians and metropolitan specialists. An identified challenge to this method of delivering care is to ensure that outreach services focus on specialties that complement existing rural provision, and are not concentrated in a specific area, neglecting more rural communities. 13 Evaluating clinical outcomes and patient experience is an important factor in ensuring service reorganisation has been successful, and building support for system change
Quality assessment
The summary of the results of the MetaQAT assessment is included in Appendix D. The overall quality of the included studies was moderate, although there was considerable variation in the quality of studies.
The choice of methodology (eg expert opinion, audit) was an important factor limiting the validity and generalisability of a number of studies, although the authors of this study acknowledge the challenge of robust evaluation of this type of service change.
Lack of clear controls or comparator cohorts was a source of potential bias for the majority of studies included in the review. Given the significant heterogeneity in outcomes, there also exists the potential for selective reporting of service data. It should also be noted that there may be publication bias associated with the implementations of MSSS models of care which have not produced improvements in quality and safety, particularly given the often political nature of this type of service change.
The findings of this review should therefore be considered in the context of what is currently an emerging evidence base with important limitations.
Discussion
One of the aims of the review was to identify a common definition of a MSSS model. A thematic analysis identified a range of models of care which have been summarised in Table 1 . Furthermore, we propose a framework to help guide the categorisation of this type of model of care in future (see Figure 2 ). Models of service delivery have been ordered by the level of centralisation of service (from least to most centralised). 
Specialist Centre
'Clinical Network Plus (+)' describes a network in which all sites provide the same treatment to patients, but some aspects of care are restricted to a smaller number of sites at certain times. For example, Agarwal et al 14 describe a Tele-stroke service delivered in the UK in which 7 hospital sites coordinate to provide thrombolysis to patients outside of core working hours, without the need for transfer to specialist centre; a regional rota of 10 clinicians working across those sites work to deliver a thrombolysis service to all sites in the network, overnight and at weekends, employing telemedicine technology to enable the specialist to communicate with local clinical teams. We found insufficient evidence to conclude which model of care was most effective or was the most appropriate solution in a given context.
The vast majority of data related to patient outcomes was positive, including reported 30-day mortality. It also appears from studies reporting measures related to patient experience that the majority of patients were satisfied with the care received via MSSS models of care.
The drivers and enablers we identified align with important aspects of service change reported elsewhere 30 31 . It appears that the local context of the service change is important in determining the relative importance of one factor versus another. Further research to describe specific challenges of different MSSS models we have described would be valuable.
The findings in our review relating to patient outcomes and experience should be placed in the context of the variation in quality of studies and the potential for bias to have affected the results presented. In order for a more robust evidence base to develop, it is important that organisations conduct rigorous evaluation and disseminate the findings of such evaluation in future. This may be challenging to prioritise in the context of service change partly driven by financial scarcity, but it is essential if the results of that service change are to be fully understood and the resultant learning disseminated.
We propose a list of outcome measures to be used in the planning of future MSSS evaluation (see Figure 3 ), developed with reference to common outcomes reported in the current evidence base, as well as consultation with the Clinical Working Group. Taken in conjunction with our proposed framework for MSSS models presented in Figure 2 , this package can form a basis for health systems to consider the most clinically appropriate model at the outset, and include evidence of the outcomes presented in Figure 3 throughout the clinical reconfiguration process from development to implementation, and through to evaluation. In England this approach will be highly relevant for Commissioners and Providers, alongside independent bodies such as Clinical Senates who have a key role providing advice on clinical reconfiguration 4 .
Figure 3. Proposed set of standardised outcome measures for future MSSS evaluation
These include:
Strengths and limitations of this review
This review is the first to outline the evidence base on MSSS models of care. We hope this review and its findings will assist health decision makers in the planning, implementation and evaluation of MSSS models. By using systematic methodology, the authors have sought to reduce error or bias that may have been introduced otherwise.
By limiting the search to peer-reviewed studies published in 2013 or after, we may have missed relevant evidence or grey literature. Given the challenge of service change research, there may be a significant number of reports published outside peer-review journals which would have added to our understanding of the research area. In addition, there may have been relevant studies published in a language other than English which we were not able to capture in this review. The recommendations and conclusions drawn by the authors must be interpreted in the context of the reported quality of the studies.
Proposed measures are: 
Intervention(s), exposure(s)
Inclusion criteria:
• studies whose focus is the delivery of a single clinical service working across multiple hospital or provider sites / geographic locations • studies whose focus may be an established model of service delivery, but one which contains some element of a hub and spoke service, a networked service, or decentralised centralisation • studies published in peer-reviewed journals • studies published between 2013 and date of search Exclusion criteria:
• studies which do not have some element of 'multiple site single service' models of care as their focus • studies not published in peer-reviewed journals • studies published prior to 2013
Comparator(s)/control
Comparator is a single service delivered by one team of people working on one site or usual practice or a previously established model of service delivery.
Main outcome(s)
The optimal definition of 'multiple site single service' models of care.
The impact of 'multiple site single service' models of care on patient outcomes and quality of care.
Additional outcome(s)
Review commonly used outcomes for 'multiple site single service' models.
Enablers and barriers to implementing / adopting 'multiple site single service' models of care. 
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